Helge Bastian, Ph.D.                                           

Dr. Bastian has more than 27 years of international leadership experience in leading life science and healthcare corporations that deliver innovative products, custom products, and services in research-use-only and regulated markets.

Most recently, Dr. Bastian has served as President & CEO and Board Member at M2GEN, an oncology-focused health informatics solutions company. Before that Dr. Bastian led the Sample Preparation and Synthetic Biology businesses at Thermo Fisher Scientific as Vice President and General Manager. Prior to Thermo Fisher Dr. Bastian served as a member of the executive leadership teams and held a number of senior leadership positions including, Managing Director and Chief Commercial Officer at Indivumed, an integrated oncology company; Vice President Global Marketing, Business Development and Strategy at Sigma-Aldrich (now Merck KGaA); Executive Vice President Life Science Services for SGS, the world’s leading inspection, verification, testing and certification company. Prior to SGS, he held various management positions during his 11-plus years at Qiagen including Vice President Molecular Diagnostics, Vice President Global Strategic Marketing, and Vice President PreAnalytiX, a QIAGEN / Becton Dickinson joint venture.

Dr. Bastian earned his diploma in biology / biochemistry from Georg-August University and holds a Ph.D. in molecular and cell biology performed at the Max-Planck Institute for Biophysical Chemistry.

Between 2014-2018, Dr. Bastian served as a board member to the International Gene Synthesis Consortium (IGSC) and is an alumnus from the Max-Planck-Network and the Columbia Business School.